Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-062117
Filing Date
2021-10-29
Accepted
2021-10-29 18:09:10
Documents
2
Period of Report
2021-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2137
2 POA DOCUMENT poa.txt EX-24 3076
  Complete submission text file 0001209191-21-062117.txt   6642
Mailing Address C/O UNILIFE CORPORATION 250 CROSS FARM LANE YORK PA 17406
Business Address
Kamarck Michael E. (Reporting) CIK: 0001450730 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39323 | Film No.: 211364637

Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)